Abiomed Inc. buy melinda
Start price
21.12.17
/
50%
€172.25
Target price
08.01.18
€187.35
Performance (%)
9.20%
End price
08.01.18
€188.10
Summary
This prediction ended on 08.01.18 with a price of €188.10. With a performance of 9.20%, the BUY prediction by melinda for Abiomed Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Abiomed Inc. | - | - | - | - |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
According to melinda what are the pros and cons of Abiomed Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Abiomed Inc. diskutieren
SecteurEquipement und moderne medizinische Technologie Agenda 01/02 Ergebnisse Veröffentlichung
Die Volatilität wird erwartet , dass ein Comeback machen
21/12/2017 Strategie KAUF
Wir werden die Position für den Kauf von $ 207,7 Ziel.
Synthese
(Zielkurs erreicht)
Stopped prediction by melinda for Abiomed Inc.
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€266.60
29.04.21
29.04.21
€245.00
29.04.22
29.04.22
-10.43%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€177.80
01.12.19
01.12.19
€300.00
04.11.21
04.11.21
49.94%
29.04.21
29.04.21
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€285.06
18.11.18
18.11.18
€329.23
28.11.18
28.11.18
5.54%
28.11.18
28.11.18
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€266.84
09.03.18
09.03.18
€306.68
07.05.18
07.05.18
17.78%
07.05.18
07.05.18
Could be worthwhile Investment >10% per year